Your browser doesn't support javascript.
loading
Crystallization Selectivity of Ribavirin Solution and Amorphous Phase.
Li, Fuying; Chen, Shiying; Hu, Haoxin; Liang, Chengfeng; Sun, Shiyu; Jin, Can; Chen, Fenghua.
  • Li F; Fujian Provincial Key Laboratory of Resources and Environment Monitoring & Sustainable Management and Utilization, Sanming University, Sanming 365004, China.
  • Chen S; Department of Engineering Technology Management, International College, Krirk University, Bangkok 10220, Thailand.
  • Hu H; Fujian Provincial Key Laboratory of Resources and Environment Monitoring & Sustainable Management and Utilization, Sanming University, Sanming 365004, China.
  • Liang C; College of Chemistry and Materials Science, Fujian Normal University, Fuzhou 350007, China.
  • Sun S; Fujian Provincial Key Laboratory of Resources and Environment Monitoring & Sustainable Management and Utilization, Sanming University, Sanming 365004, China.
  • Jin C; Fujian Provincial Key Laboratory of Resources and Environment Monitoring & Sustainable Management and Utilization, Sanming University, Sanming 365004, China.
  • Chen F; Torch High Technology Industry Development Center, Ministry of Science and Technology, Beijing 100045, China.
Molecules ; 28(17)2023 Aug 29.
Article en En | MEDLINE | ID: mdl-37687147
ABSTRACT
Crystallization selectivity is an important principle in polymorph control. Ribavirin Form I, Form II, DMSO solvate, and amorphous ribavirin are prepared, and the short-range order similarities between these solid forms and ribavirin aqueous solution and DMSO solution are compared via mid-frequency Raman difference spectra (MFRDS). The crystallization process from amorphous ribavirin to Form I and from solution to amorphous phase is explained. Reasons for the difficulty in preparing the DMSO solvate are proposed. The rationale provided for the crystallization selectivity provides a foundation for the synthesis of metastable phases with a robust and convenient method.
Palabras clave